Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sanofi (SNY) Income from Continuing Operations (2016 - 2026)

Sanofi's Income from Continuing Operations history spans 16 years, with the latest figure at 3183257422.56 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 1.59% to 3183257422.56 in Q1 2026 year-over-year; TTM through Mar 2026 was 12508708619.46, a 6.68% decrease, with the full-year FY2025 number at 5973871317.43, up 1.75% from a year prior.
  • Income from Continuing Operations hit 3183257422.56 in Q1 2026 for Sanofi, up from 3714462855.4 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for SNY hit a ceiling of 11951177637.09 in Q4 2022 and a floor of 3714462855.4 in Q4 2025.
  • Historically, Income from Continuing Operations has averaged 4017693589.13 across 5 years, with a median of 3161625352.61 in 2022.
  • Biggest five-year swings in Income from Continuing Operations: surged 4022.77% in 2022 and later plummeted 221.97% in 2025.
  • Tracing SNY's Income from Continuing Operations over 5 years: stood at 11951177637.09 in 2022, then fell by 16.54% to 9973962956.26 in 2023, then tumbled by 69.47% to 3045496890.46 in 2024, then crashed by 221.97% to 3714462855.4 in 2025, then surged by 185.7% to 3183257422.56 in 2026.
  • Business Quant data shows Income from Continuing Operations for SNY at 3183257422.56 in Q1 2026, 3714462855.4 in Q4 2025, and 10943524710.14 in Q3 2025.